Showing 1 - 2 results of 2 for search 'Jae Lyun Lee', query time: 0.01s Refine Results
  1. 1
    First‐In‐Human Dose Finding Study of Venadaparib (IDX‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors

    First‐In‐Human Dose Finding Study of Venadaparib (IDX‐1197), a Potent and Selective PARP Inhibitor, in Patients With Advanced Solid Tumors by Sung‐Bae Kim, Kyun‐Seop Bae, Jae Lyun Lee, Won Sik Lee, Chan‐Young Ock, Myong‐Jae Lee, Jeongsook Bang, Min Ju Hong, Eun‐Jihn Roh, Kyoung Soo Ha, Jong‐Ha Lim, Yong‐Man Kim

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bisceglia criteria

    Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed... by Byung-Chang Kim, HyeJin Han, Douk Kwon, Shin Jeong Pak, Hyeong Rok An, Won Woong Kim, Yu-Mi Lee, Seung Hun Lee, Jung-Min Koh, Jae Lyun Lee, Ki-Wook Chung, Dong Eun Song, Tae-Yon Sung

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: